Adicet Bio (ACET) Earnings Analysis

Adicet Bio (ACET) next reports earnings on 2026-08-06, consensus EPS -1.692 USD. Last quarter (2026-03-12) it beat with EPS -2.94 USD vs -3.23 USD est (+9%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E -0.58.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ACET next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate-1.692 USD
Revenue estimaten/a

ACET earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-12-2.94 USD-3.23 USD+9%Beat
2025-08-07-5.44 USD-4.86171 USD-11.9%Miss
2025-03-06-5.12 USD-5.92 USD+13.5%Beat

Beat rate: 2/3 (67%) over reported quarters with consensus data.

ACET valuation and analyst view

Trailing P/E-0.58
Trailing EPS-10.12907 USD
Price / book0.66
Dividend yield0.00%
Market cap0.08B
Analyst consensusBuy (9 buy / 3 hold / 0 sell)
Avg price target18 USD

Related research pages

Frequently asked questions

When is Adicet Bio (ACET)'s next earnings date?

Adicet Bio is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -1.692 USD.

Did ACET beat earnings last quarter?

In its 2026-03-12 report, ACET posted EPS of -2.94 USD versus a -3.23 USD estimate — a beat of 9%.

What is ACET's earnings track record?

Over the last 3 reported quarters with consensus data, ACET beat estimates 2 times (67%).

What is ACET's current P/E ratio and EPS?

ACET trades at a trailing P/E of -0.58 on trailing EPS of -10.129068303107202 USD.

What do analysts rate ACET?

Analyst consensus is "Buy" across 12 ratings (0 strong buy, 9 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 18 USD.